Trials / Sponsors / Guangzhou FineImmune Biotechnology Co., LTD.
Guangzhou FineImmune Biotechnology Co., LTD.
Industry · 5 registered clinical trials — 5 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | An Open-Label, Phase I Clinical Trial of Super CAR-T With GPC3-Positive Advanced Hepatocellular Carcinoma Advanced Hepatocellular Carcinoma (HCC), GPC3 Positive Hepatocellular Carcinoma | Phase 1 | 2026-03-20 |
| Recruiting | An Open-label, Phase I Clinical Trial of Super1 TCR-T in NY-ESO-1-positive Patients With Advanced Solid Tumors Sarcoma, Lung Cancers, Melanoma | Phase 1 | 2025-05-22 |
| Recruiting | A Phase I Trial of Tumor-Associated Lymph Node T-Cell Injection With Advanced Malignant Solid Tumors Tumor Associated Lymph Node T Cell, Advanced Solid Tumor, Immunotherapy | Phase 1 | 2025-02-13 |
| Recruiting | Phase I Clinical Study of Tumor-associated Lymph Node T Cell Therapy for Advanced Solid Tumors Advanced Solid Tumor, Tumor Associated Lymph Node T Cell, Immunotherapy | Phase 1 | 2023-06-06 |
| Recruiting | Individualized Tumor Specific TCR- T Cells in the Treatment of Advanced Solid Tumors Solid Tumor | Phase 1 | 2019-01-08 |